Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Saxne

Showing results (91-100 of 113) with videos related to

Pageof 12
Sort By:
The Journal of Clinical Investigation|March 1, 1995
Cartilage and bone metabolism in rheumatoid arthritis. Differences between rapid and slow progression of disease identified by serum markers of cartilage metabolismB Månsson, D Carey, M Alini, et al.
Annals of the Rheumatic Diseases|November 18, 2010
Generalisability of clinical registers used for drug safety and comparative effectiveness research: coverage of the Swedish Biologics RegisterM Neovius, Jf Simard, A Sundström, et al.
Scandinavian Journal of Rheumatology|February 7, 2015
The risk of pneumococcal infections after immunization with pneumococcal conjugate vaccine compared to non-vaccinated inflammatory arthritis patientsJ Nagel, P Geborek, T Saxne, et al.
Annals of the Rheumatic Diseases|May 19, 2006
Diurnal variation in serum levels of cartilage oligomeric matrix protein in patients with knee osteoarthritis or rheumatoid arthritisM L E Andersson, I F Petersson, K E Karlsson, et al.
Annals of the Rheumatic Diseases|February 8, 2005
Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomasP Geborek, A Bladström, C Turesson, et al.
Arthritis and Rheumatism|January 27, 1999
Changes in serum cartilage marker levels indicate altered cartilage metabolism in families with the osteoarthritis-related type II collagen gene COL2A1 mutationJ F Bleasel, A R Poole, D Heinegård, et al.
Annals of the Rheumatic Diseases|June 18, 2003
Radiographic joint destruction in postmenopausal rheumatoid arthritis is strongly associated with generalised osteoporosisH Forsblad D'Elia, A Larsen, E Waltbrand, et al.
Molecular Immunology|August 14, 2009
Interactions of histidine-rich glycoprotein with immunoglobulins and proteins of the complement systemG A Manderson, M Martin, P Onnerfjord, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 1999
IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammationL A Joosten, M M Helsen, T Saxne, et al.
Scandinavian Journal of Rheumatology|October 19, 2010
The number needed to treat for second-generation biologics when treating established rheumatoid arthritis: a systematic quantitative review of randomized controlled trialsL E Kristensen, A K Jakobsen, E M Bartels, et al.
Pageof 12

Showing results (91-100 of 113) with videos related to

Sort By:
Pageof 12
The Journal of Clinical Investigation|March 1, 1995
Cartilage and bone metabolism in rheumatoid arthritis. Differences between rapid and slow progression of disease identified by serum markers of cartilage metabolismB Månsson, D Carey, M Alini, et al.
Annals of the Rheumatic Diseases|November 18, 2010
Generalisability of clinical registers used for drug safety and comparative effectiveness research: coverage of the Swedish Biologics RegisterM Neovius, Jf Simard, A Sundström, et al.
Scandinavian Journal of Rheumatology|February 7, 2015
The risk of pneumococcal infections after immunization with pneumococcal conjugate vaccine compared to non-vaccinated inflammatory arthritis patientsJ Nagel, P Geborek, T Saxne, et al.
Annals of the Rheumatic Diseases|May 19, 2006
Diurnal variation in serum levels of cartilage oligomeric matrix protein in patients with knee osteoarthritis or rheumatoid arthritisM L E Andersson, I F Petersson, K E Karlsson, et al.
Annals of the Rheumatic Diseases|February 8, 2005
Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomasP Geborek, A Bladström, C Turesson, et al.
Arthritis and Rheumatism|January 27, 1999
Changes in serum cartilage marker levels indicate altered cartilage metabolism in families with the osteoarthritis-related type II collagen gene COL2A1 mutationJ F Bleasel, A R Poole, D Heinegård, et al.
Annals of the Rheumatic Diseases|June 18, 2003
Radiographic joint destruction in postmenopausal rheumatoid arthritis is strongly associated with generalised osteoporosisH Forsblad D'Elia, A Larsen, E Waltbrand, et al.
Molecular Immunology|August 14, 2009
Interactions of histidine-rich glycoprotein with immunoglobulins and proteins of the complement systemG A Manderson, M Martin, P Onnerfjord, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 1999
IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammationL A Joosten, M M Helsen, T Saxne, et al.
Scandinavian Journal of Rheumatology|October 19, 2010
The number needed to treat for second-generation biologics when treating established rheumatoid arthritis: a systematic quantitative review of randomized controlled trialsL E Kristensen, A K Jakobsen, E M Bartels, et al.
Pageof 12